Back to Search
Start Over
Molecular monitoring during dose reduction predicts recurrence after TKI cessation in CML
- Source :
- Blood. 135(10)
- Publication Year :
- 2020
- Subjects :
- Oncology
Drug
medicine.medical_specialty
media_common.quotation_subject
Immunology
Biochemistry
Myelogenous
Remission induction
Recurrence
Internal medicine
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
medicine
Humans
Progression-free survival
Protein Kinase Inhibitors
media_common
Clinical Trials as Topic
Withholding Treatment
Dose-Response Relationship, Drug
business.industry
Remission Induction
Cell Biology
Hematology
medicine.disease
Prognosis
Progression-Free Survival
Leukemia
Dose–response relationship
Molecular Diagnostic Techniques
Dose reduction
Drug Monitoring
business
Subjects
Details
- ISSN :
- 15280020
- Volume :
- 135
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Blood
- Accession number :
- edsair.doi.dedup.....18de3b7b08f8f12099d33a94f3d0a412